@szhao.bsky.social
🚨The incidence of #uveitis and #IBD in psoriatic disease, and vice versa, is not well described.
This study shows, among other things, that uveitis and IBD incidences are higher in #PsA than cutaneous-only #psoriasis and higher in females than males.
academic.oup.com/rheumatology...
This study shows, among other things, that uveitis and IBD incidences are higher in #PsA than cutaneous-only #psoriasis and higher in females than males.
academic.oup.com/rheumatology...
March 5, 2025 at 11:21 AM
🚨The incidence of #uveitis and #IBD in psoriatic disease, and vice versa, is not well described.
This study shows, among other things, that uveitis and IBD incidences are higher in #PsA than cutaneous-only #psoriasis and higher in females than males.
academic.oup.com/rheumatology...
This study shows, among other things, that uveitis and IBD incidences are higher in #PsA than cutaneous-only #psoriasis and higher in females than males.
academic.oup.com/rheumatology...
🚨 #Tofacitinib ⬆️ #cardiovascular & #cancer risk in RA. But how relevant is this risk to people with #AxialSpondyloarthritis or #PsoriaticArthritis?
This study did not find ⬆️risk of JAK compared to TNF or IL17 inhibitors in SpA. Funded by PAPAA.
www.sciencedirect.com/science/arti...
This study did not find ⬆️risk of JAK compared to TNF or IL17 inhibitors in SpA. Funded by PAPAA.
www.sciencedirect.com/science/arti...
Comparative safety of JAK inhibitors versus TNF or IL-17 inhibitors for cardiovascular disease and cancer in psoriatic arthritis and axial spondyloarthritis
To compare the risk of cardiovascular disease (CVD) and common solid cancers between JAK inhibitors (JAKi) versus TNF or IL-17 inhibitors, among peopl…
www.sciencedirect.com
March 4, 2025 at 1:02 PM
🚨 #Tofacitinib ⬆️ #cardiovascular & #cancer risk in RA. But how relevant is this risk to people with #AxialSpondyloarthritis or #PsoriaticArthritis?
This study did not find ⬆️risk of JAK compared to TNF or IL17 inhibitors in SpA. Funded by PAPAA.
www.sciencedirect.com/science/arti...
This study did not find ⬆️risk of JAK compared to TNF or IL17 inhibitors in SpA. Funded by PAPAA.
www.sciencedirect.com/science/arti...